Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 3
1953 1
1954 1
1955 1
1956 3
1958 2
1959 2
1960 2
1962 1
1964 3
1965 2
1966 2
1967 2
1968 1
1972 1
1973 1
1976 2
1978 3
1979 7
1980 5
1981 5
1982 4
1983 4
1984 7
1985 12
1986 10
1987 11
1988 14
1989 3
1990 10
1991 8
1992 4
1993 6
1994 6
1995 6
1996 10
1997 12
1998 6
1999 9
2000 11
2001 16
2002 8
2003 23
2004 18
2005 19
2006 12
2007 22
2008 28
2009 25
2010 17
2011 17
2012 28
2013 15
2014 12
2015 15
2016 15
2017 9
2018 11
2019 9
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

497 results
Results by year
Filters applied: . Clear all
Page 1
Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Falck-Ytter Y, et al. Among authors: Dahl OE. Chest. 2012 Feb;141(2 Suppl):e278S-e325S. doi: 10.1378/chest.11-2404. Chest. 2012. PMID: 22315265 Free PMC article.
B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Fluge Ø, Rekeland IG, Lien K, Thürmer H, Borchgrevink PC, Schäfer C, Sørland K, Aßmus J, Ktoridou-Valen I, Herder I, Gotaas ME, Kvammen Ø, Baranowska KA, Bohnen LMLJ, Martinsen SS, Lonar AE, Solvang AH, Gya AES, Bruland O, Risa K, Alme K, Dahl O, Mella O. Fluge Ø, et al. Among authors: Dahl O. Ann Intern Med. 2019 May 7;170(9):585-593. doi: 10.7326/M18-1451. Epub 2019 Apr 2. Ann Intern Med. 2019. PMID: 30934066 Clinical Trial.
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.
Fluge Ø, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, Rekeland IG, Sapkota D, Røsland GV, Fosså A, Ktoridou-Valen I, Lunde S, Sørland K, Lien K, Herder I, Thürmer H, Gotaas ME, Baranowska KA, Bohnen LM, Schäfer C, McCann A, Sommerfelt K, Helgeland L, Ueland PM, Dahl O, Tronstad KJ. Fluge Ø, et al. Among authors: Dahl O. JCI Insight. 2016 Dec 22;1(21):e89376. doi: 10.1172/jci.insight.89376. JCI Insight. 2016. PMID: 28018972 Free PMC article.
O.E. Dahl og medarbeidere svarer.
Dahl OE, Reikerås O, Pripp AH, Engesæter LB. Dahl OE, et al. Tidsskr Nor Laegeforen. 2018 Jun 12;138(10). doi: 10.4045/tidsskr.18.0446. Print 2018 Jun 12. Tidsskr Nor Laegeforen. 2018. PMID: 29893092 Free article. Norwegian. No abstract available.
Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
Gaare JJ, Nido GS, Sztromwasser P, Knappskog PM, Dahl O, Lund-Johansen M, Maple-Grødem J, Alves G, Tysnes OB, Johansson S, Haugarvoll K, Tzoulis C. Gaare JJ, et al. Among authors: Dahl O. Mov Disord. 2018 Oct;33(10):1591-1600. doi: 10.1002/mds.64. Epub 2018 Sep 5. Mov Disord. 2018. PMID: 30256453 Free PMC article.
Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis.
Myklebust MP, Rosenlund B, Gjengstø P, Bercea BS, Karlsdottir Á, Brydøy M, Dahl O. Myklebust MP, et al. Among authors: Dahl O. Front Genet. 2019 May 22;10:463. doi: 10.3389/fgene.2019.00463. eCollection 2019. Front Genet. 2019. PMID: 31191602 Free PMC article.
Low-molecular-weight heparin for hip fracture patients treated with osteosynthesis: should thromboprophylaxis start before or after surgery? An observational study of 45,913 hip fractures reported to the Norwegian Hip Fracture Register.
Leer-Salvesen S, Dybvik E, Engesaeter LB, Dahl OE, Gjertsen JE. Leer-Salvesen S, et al. Among authors: Dahl OE. Acta Orthop. 2018 Dec;89(6):615-621. doi: 10.1080/17453674.2018.1519101. Epub 2018 Oct 17. Acta Orthop. 2018. PMID: 30328746 Free PMC article. Clinical Trial.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Büller HR; RE-NOVATE Study Group. Eriksson BI, et al. Among authors: Dahl OE. Lancet. 2007 Sep 15;370(9591):949-56. doi: 10.1016/S0140-6736(07)61445-7. Lancet. 2007. PMID: 17869635 Clinical Trial.
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A, Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Ribeiro U Jr, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M. Bass AJ, et al. Among authors: Dahl O. Nat Genet. 2009 Nov;41(11):1238-42. doi: 10.1038/ng.465. Epub 2009 Oct 4. Nat Genet. 2009. PMID: 19801978 Free PMC article.
497 results
Jump to page